- Home
- SQFT vs BDRX Comparison
SQFT vs BDRX Comparison
Compare SQFT & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- BDRX
- Stock Information
- Founded
- SQFT 1999
- BDRX 2000
- Country
- SQFT United States
- BDRX United Kingdom
- Employees
- SQFT N/A
- BDRX N/A
- Industry
- SQFT Real Estate Investment Trusts
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- BDRX Health Care
- Exchange
- SQFT Nasdaq
- BDRX Nasdaq
- Market Cap
- SQFT 6.2M
- BDRX 5.8M
- IPO Year
- SQFT 2020
- BDRX N/A
- Fundamental
- Price
- SQFT $5.15
- BDRX $0.87
- Analyst Decision
- SQFT
- BDRX
- Analyst Count
- SQFT 0
- BDRX 0
- Target Price
- SQFT N/A
- BDRX N/A
- AVG Volume (30 Days)
- SQFT 12.4K
- BDRX 3.1M
- Earning Date
- SQFT 08-13-2025
- BDRX 04-11-2025
- Dividend Yield
- SQFT N/A
- BDRX N/A
- EPS Growth
- SQFT N/A
- BDRX N/A
- EPS
- SQFT N/A
- BDRX N/A
- Revenue
- SQFT $18,260,398.00
- BDRX N/A
- Revenue This Year
- SQFT $23.63
- BDRX N/A
- Revenue Next Year
- SQFT N/A
- BDRX N/A
- P/E Ratio
- SQFT N/A
- BDRX N/A
- Revenue Growth
- SQFT N/A
- BDRX N/A
- 52 Week Low
- SQFT $4.19
- BDRX $0.78
- 52 Week High
- SQFT $8.77
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- SQFT 51.05
- BDRX 38.67
- Support Level
- SQFT $4.55
- BDRX $0.85
- Resistance Level
- SQFT $5.77
- BDRX $0.92
- Average True Range (ATR)
- SQFT 0.37
- BDRX 0.06
- MACD
- SQFT 0.09
- BDRX 0.01
- Stochastic Oscillator
- SQFT 56.96
- BDRX 32.73
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.